Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-33,200
Closed -$4.12M 3740
2018
Q4
$4.12M Hold
33,200
0.01% 1640
2018
Q3
$8.11M Buy
33,200
+23,300
+235% +$5.39M 0.01% 1236
2018
Q2
$1.84M Buy
+9,900
New +$1.65M ﹤0.01% 2281

Other funds holding INGN

David Shaw's INGN Position: Q2 2026 in Review

David Shaw reduced its Inogen (INGN) stake by 20% in Q2 2026, selling an estimated $62.7K and leaving 37,171 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #4498.

David Shaw first reported a position in INGN in Q1 2015 and has held it in 26 quarters since. The position peaked at $24.9M in Q4 2019. 128 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • David Shaw held 37,171 shares of Inogen worth $240K as of Q2 2026.
  • David Shaw sold 9,472 Inogen shares in Q2 2026, an estimated $62.7K.
  • Inogen made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4498 holding.
  • David Shaw first reported a position in Inogen in Q1 2015 and has held it in 26 quarters since.
  • David Shaw's Inogen position peaked at $24.9M in Q4 2019.
  • 128 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.